Universe Pharmaceuticals INC (UPC)
USD 0.68
(-0.8%)
USD 0.68
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.12 Million | -1.31 Million | -2.05 Million | 6.11 Million | 13.2 Million | 4.45 Million |
| Net Income | -6.16 Million | -8.73 Million | 11.31 Million | 7.55 Million | 7.55 Million | 7.6 Million |
| Depreciation & Amortization | 508.78 Thousand | 533.94 Thousand | 446.87 Thousand | 410.07 Thousand | 418.43 Thousand | 452.73 Thousand |
| Deferred income taxes | 679.58 Thousand | -605.27 Thousand | -668.34 Thousand | -9886.00 | -39.62 Thousand | 17.53 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 6.62 Million | 6.58 Million | -12.68 Million | -1.86 Million | 5.16 Million | -3.53 Million |
| Other non-cash items | -526.9 Thousand | 906.58 Thousand | -468.16 Thousand | 22.71 Thousand | 112.78 Thousand | -85.19 Thousand |
| Investing Cash Flow | -44.16 Thousand | -3.9 Million | -27.05 Million | -51.79 Thousand | -86.03 Thousand | -145.09 Thousand |
| Investments in PPE | -44.16 Thousand | -93.7 Thousand | -13.53 Million | -51.79 Thousand | -86.32 Thousand | -145.09 Thousand |
| Acquisitions | - | -3.81 Million | 26.61 Million | - | 291.00 | - |
| Investment purchases | - | - | -15.33 Million | - | - | - |
| Sales/Maturities of investments | - | - | 1.8 Million | - | - | - |
| Other Investing Activities | - | 523.00 | -26.61 Million | - | - | - |
| Financing Cash Flow | -1.39 Million | 3.31 Million | 26.58 Million | 470.13 Thousand | -16 Million | -4.91 Million |
| Debt repayment | -3.96 Million | -4.27 Million | -3.67 Million | -1.42 Million | -3.05 Million | -5.5 Million |
| Dividends payments | - | - | - | - | -16 Million | -3.06 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 28.75 Million | - | - | - |
| Other Financing Activities | 2.57 Million | 7.59 Million | 1.5 Million | 1.89 Million | 3.05 Million | 3.65 Million |
| Accounts receivables | 4.71 Million | -1.54 Million | -3.86 Million | -4.1 Million | 665.48 Thousand | -2.81 Million |
| Accounts payables | 1.64 Million | -1.89 Million | 2.45 Million | 639.42 Thousand | -924.44 Thousand | 265.17 Thousand |
| Inventory | -1.18 Million | 16.58 Thousand | -451.63 Thousand | 888.6 Thousand | 5.58 Million | -327.25 Thousand |
| Other working capital | 1.44 Million | 10.01 Million | -10.82 Million | 713.51 Thousand | -166.52 Thousand | -654.88 Thousand |
| Cash at beginning of period | 5.71 Million | 8.07 Million | 10.05 Million | 3.17 Million | 6.19 Million | 6.98 Million |
| Cash at end of period | 5.28 Million | 5.71 Million | 8.07 Million | 10.05 Million | 3.17 Million | 6.19 Million |
| Capital Expenditure | -44.16 Thousand | -93.7 Thousand | -13.53 Million | -51.79 Thousand | -86.32 Thousand | -145.09 Thousand |
| Effect of forex changes on cash | -111.47 Thousand | -463.94 Thousand | 553.7 Thousand | 347.38 Thousand | -126.72 Thousand | -189.16 Thousand |
| Net cash flow / Change in cash | -426.21 Thousand | -2.36 Million | -1.98 Million | 6.88 Million | -3.01 Million | -793.23 Thousand |
| Free Cash Flow | 1.07 Million | -1.4 Million | -15.58 Million | 6.06 Million | 13.11 Million | 4.31 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.1 Million | -6.16 Million | -5.44 Million | -715.42 Thousand | -8.73 Million | -10.46 Million |
| Depreciation & Amortization | 248.86 Thousand | 508.78 Thousand | 251 Thousand | 257.78 Thousand | 533.94 Thousand | 241.83 Thousand |
| Deferred income taxes | 665.14 Thousand | 679.58 Thousand | 122.71 Thousand | 556.86 Thousand | -605.27 Thousand | -504.87 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -653.92 Thousand | 6.62 Million | 1.67 Million | 4.95 Million | 6.58 Million | 1.78 Million |
| Other non-cash items | 10.41 Million | -526.9 Thousand | 748.12 Thousand | -5.22 Million | 906.58 Thousand | -3.39 Million |
| Investing Cash Flow | -67.65 Thousand | -44.16 Thousand | -43.52 Thousand | -646.00 | -3.9 Million | -3.85 Million |
| Investments in PPE | -67.65 Thousand | -44.16 Thousand | -43.52 Thousand | -646.00 | -93.7 Thousand | -38.07 Thousand |
| Acquisitions | - | - | - | - | -3.81 Million | -15.00 |
| Investment purchases | -313.54 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | 313.54 Thousand | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 523.00 | -3.81 Million |
| Financing Cash Flow | 6.06 Million | -1.39 Million | -3.47 Million | 2.08 Million | 3.31 Million | 3.33 Million |
| Debt repayment | -6.06 Million | -3.96 Million | -3.47 Million | -2.08 Million | -4.27 Million | -3.33 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 2.57 Million | - | - | 7.59 Million | 6.67 Million |
| Accounts receivables | -3.34 Million | 4.71 Million | 6.48 Million | -1.76 Million | -1.54 Million | 1.51 Million |
| Accounts payables | 3.13 Million | 1.64 Million | -6.28 Million | 7.92 Million | -1.89 Million | -145.6 Thousand |
| Inventory | -160.22 Thousand | -1.18 Million | -677.63 Thousand | -676.2 Thousand | 16.58 Thousand | 3.55 Million |
| Other working capital | -284.15 Thousand | 1.44 Million | 2.15 Million | -536.71 Thousand | 10.01 Million | -3.14 Million |
| Cash at beginning of period | 5.28 Million | 5.71 Million | 12.95 Million | 5.71 Million | 8.07 Million | 14.23 Million |
| Cash at end of period | 8.86 Million | 5.28 Million | 5.28 Million | 12.95 Million | 5.71 Million | 5.71 Million |
| Capital Expenditure | -67.65 Thousand | -44.16 Thousand | -43.52 Thousand | -646.00 | -93.7 Thousand | -38.07 Thousand |
| Effect of forex changes on cash | - | -111.47 Thousand | -514.09 Thousand | 364.08 Thousand | -463.94 Thousand | 9.99 Million |
| Net cash flow / Change in cash | 3.57 Million | -426.21 Thousand | -7.66 Million | 7.24 Million | -2.36 Million | -8.52 Million |
| Free Cash Flow | -2.49 Million | 1.07 Million | -3.68 Million | 4.79 Million | -1.4 Million | -7.93 Million |
GDSI
PDGR3
GLA1V
4123
1580
VLS